Teligent Pharma, Inc. 2022-01-05 Health serious FDA
Health · FDA · Recall #FDA-D-0297-2022
Betamethasone Dipropionate Lotion USP, 0.05% (Augmented), 30 mL bottle, (29 g), Rx Only, … Recall
Issued January 5, 2022 · Teligent Pharma, Inc.
In January 2022, Teligent Pharma, Inc. recalled the Betamethasone Dipropionate Lotion USP, 0.05% (Augmented), 30 mL bottle, (29 g), Rx Only, …, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API) particle test, which was determined through routine stability testing
What you should do
- 1 Stop using Betamethasone Dipropionate Lotion USP, 0.05% (Augmented), 30 mL bottle, (29 g), Rx Only, … right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Teligent Pharma, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Teligent Pharma, Inc.
- Category
- Health
- Recall date
- January 5, 2022
- Units affected
- Not reported
- Sold at
- Distributed Nationwide in the USA
- Recall number
- FDA-D-0297-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Teligent Pharma, Inc. has 17 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.